EPO logo
EPO boards of appeal decisions
homepage => search & index => boards of appeal decisions
Search mask List of updates
Date of decision 28 July 1994
Case number T 0296/93 - 3.3.4
Application number 85201908.2
IPC C12N15/51
Proceedings Language EN
Title of the application Recombinant DNA molecules and their method of production
Applicant name BIOGEN. INC.
Opponent name (01) INTERNATIONAL MUREX TECHNOLOGIES CORPORATION
(02) Institut Pasteur Etablissement public
(03) IMMUNO Aktiengesellschaft
(04) Hexal-Biotech GmbH
(05) Medeva PLC
Headnote
The applicable starting point for calculating the three month period for intervention under Article 105(1) EPC is always the date of the institution of the first court action. Where a court action for infringement was first brought by a patentee against an alleged infringer, Article 105(1) EPC first sentence applies, even though the latter later instituted a court action seeking a declaration of non-infringement under Article 105(1) EPC second sentence, with regard to the same patent.
Articles and Rules EPC . Art 56
. Art 87
. Art 105(1)
Keywords
Admissibility of intervention of assumed infringer (no) - too late
Entitlement to priority (yes) - same invention
Citability of prior art document (no)
Novelty (yes)
Inventive step (yes)
Enlarged Board - referral (no)
Cited Decisions T 0301/87
T 0081/87
T 0073/88
T 0500/91
T 0886/91
T 0292/85
T 0595/90
G 0004/91
G 0001/94
T 0381/87
Catchwords:
-

get the full pdf
 

EPO Home Page | Recent updates | Request info | Send comments | Index
Patent information on the internet


Copyright © 1997-2000 European Patent Office . All Rights Reserved.
E-mail: EPO Mail Distribution